Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLC

HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult

Din Denver în întreaga lume: Cum s-a distins League of Whale Fall pe piețele financiare globale

Toys to Promote Well-being for the Elderly Designed by Chula Lecturers

BANGKOK,Feb. 10,2025-- AChulalecturer,Associate Professor Pornthep Lertthewasiri,has developed innovative "toys and home decorations for the elderly" to enhance their physical and mental wel

ChipMOS REPORTS JANUARY 2025 REVENUE

HSINCHU,Feb. 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider of

Tech Applied Summit Opens in Hong Kong

Boosting Innovation and Competitiveness through Industry Collaboration HONG KONG,Feb. 10,2025-- Tech Applied Summit,Hong Kong\'s first premier innovation and technology event in 2025,opened today at t